Author： Bracarda Sergio Castellano Daniel Procopio Giuseppe Sepúlveda Juan M Sisani Michele Verzoni Elena Schmidinger Manuela
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.13, Iss.4, 2014-04, pp. : 497-510
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Axitinib for the Management of Metastatic Renal Cell Carcinoma
Drugs in R&D, Vol. 11, Iss. 2, 2011-06 ,pp. :
Access to resources
Recommend
By Shaheen Philip Stadler Walter Elson Paul Knox Jennifer Winquist Eric Bukowski Ronald
Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. :
Ramucirumab in metastatic renal cell carcinoma: The beginning or the end?
By Pal Sumanta K. Figlin Robert A.
Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. :
Emerging Targeted Therapies in Metastatic Renal Cell Carcinoma
Current Clinical Pharmacology, Vol. 6, Iss. 3, 2011-08 ,pp. :
Emerging Immunotargets in Metastatic Renal Cell Carcinoma
Current Drug Targets, Vol. 17, Iss. 7, 2016-06 ,pp. :